Cell and Gene Outsourcing

  1. Solving The Scientific Talent Gap With Flexible Insourcing 3/16/2026

    High turnover in scientific labs drives hidden costs—from lost expertise to productivity gaps and compliance risks. Flexible insourcing offers a strategic way to stabilize operations.

  2. mbDNA™: The Smarter DNA For Non-Viral Gene Editing 3/13/2026

    A next‑gen single‑stranded DNA template improves non‑viral gene editing by boosting viability, knock‑in efficiency, delivery flexibility, and stability while overcoming limits of viral vectors.

  3. ElevateBio Capabilities Update March 2026: Cell & Gene Therapy 3/12/2026

    Learn how to embed process development expertise early and continuously to eliminate knowledge gaps, reduce risk, and ensure consistent, high-quality execution from transfer through manufacturing.

  4. Accelerating Technology Diffusion In Cell And Gene Therapy 3/11/2026

    Unlike most other drugs, advanced therapies require complex, purpose-built supply chain networks. Making them requires cross-sector collaboration.

  5. ROIS Capabilities Update March 2026: Fill/Finish 3/10/2026

    End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.

  6. Novartis Capabilities Update March 2026: Fill/Finish 3/10/2026

    Integrated fill‑finish capabilities across multiple sterile formats improve workflow efficiency, enhance product consistency, and support effective planning for scaling and long‑term commercialization.

  7. medac CDMO Capabilities Update March 2026: Fill/Finish 3/10/2026

    A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.

  8. Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish 3/10/2026

    Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.

  9. Precision Control In Animal‑Free Raw Materials 3/10/2026

    Animal‑free raw materials offer adjustable attributes, controlled manufacturing, and consistent nutrient profiles, ensuring reliable performance and customizable solutions across multiple production processes.

  10. Consistency Engineered For Animal‑Free Bioprocessing 3/10/2026

    Animal‑free soy‑based materials provide consistent molecular weight profiles, stable mineral levels, and controlled manufacturing to ensure reliable, reproducible bioprocessing performance.